Andreessen Horowitz is all about the bio

Marc Andreessen has done an about-face on health care. A decade back, the famed Silicon Valley VC proclaimed his firm would never invest in the life sciences — but now, Andreessen Horowitz is launching its third fund  dedicated to health and biology, STAT’s Erin Brodwin writes. 

Biofund III, as it’s called, will direct its $750 million toward startups that run the medical gamut — from better drug design to health care delivery tech. The common thread among these investments will be how biology melds with technology, because the two are becoming increasingly intertwined. 

Read more.